David S. Tierney - Apr 5, 2023 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Director
Signature
/s/ David S. Tierney
Stock symbol
CPRX
Transactions as of
Apr 5, 2023
Transactions value $
-$481,200
Form type
4
Date filed
4/7/2023, 05:00 PM
Previous filing
Mar 13, 2023
Next filing
May 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $23.7K +30K +9.57% $0.79 344K Apr 5, 2023 Direct
transaction CPRX Common stock, par value $0.001 per share Sale -$505K -30K -8.73% $16.83 314K Apr 5, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -30K -9.66% $0.00 281K Apr 5, 2023 Common Stock 30K $0.79 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Dr. Tierney has advised the Company that the sale of shares was to pay the exercise price of the shares and to raise funds for personal reasons, and does not relate to any disagreements between Dr. Tierney and the Company on any matter relating to the Company's operations, policies or practices. Dr. Tierney remains a Director of the Company.
F2 Shares were sold in various lots from $16.70 to $16.98 per share. The listed sales price represents a weighted average price for the shares sold.
F3 The option was granted on June 15, 2016 and previously vested in two annual installments.